Invention Grant
- Patent Title: Cellular compositions for use in therapy
- Patent Title (中): 用于治疗的细胞组合物
-
Application No.: US13132475Application Date: 2009-12-07
-
Publication No.: US09265795B2Publication Date: 2016-02-23
- Inventor: Andrew Hope , Erik Miljan , John Sinden
- Applicant: Andrew Hope , Erik Miljan , John Sinden
- Applicant Address: GB
- Assignee: RENEURON LIMITED
- Current Assignee: RENEURON LIMITED
- Current Assignee Address: GB
- Agency: Saliwanchick, Lloyd & Eisenschenk
- Priority: GB0822246.5 20081205
- International Application: PCT/GB2009/051659 WO 20091207
- International Announcement: WO2010/064054 WO 20100610
- Main IPC: A61K35/12
- IPC: A61K35/12 ; A61K9/48 ; A61K35/28 ; A61K9/19 ; A61K38/06 ; A61L27/38
Abstract:
The present invention provides a therapeutic composition comprising: (i) Trolox, Na+, K+, Ca2+, Mg2+, Cl−, H2PO4−, HEPES, lactobionate, sucrose, mannitol, glucose, dextran-40, adenosine, glutathione; and (ii) stem cells or progenitor cells, wherein the composition does not comprise a dipolar aprotic solvent, in particular DMSO. The present invention also relates to methods of formulating said composition for cryopreservation and subsequent direct administration to a patient, and medicaments comprising said composition.
Public/Granted literature
- US20120076854A1 CELLULAR COMPOSITIONS FOR USE IN THERAPY Public/Granted day:2012-03-29
Information query
